Your browser doesn't support javascript.
loading
An overview of nanogel-based vaccines.
Hernández-Adame, Luis; Angulo, Carlos; García-Silva, Ileana; Palestino, Gabriela; Rosales-Mendoza, Sergio.
Afiliação
  • Hernández-Adame L; CONACYT-Centro de Investigaciones Biológicas del Noroeste (CIBNOR), Instituto Politécnico Nacional 195 , La Paz , Mexico.
  • Angulo C; Immunology & Vaccinology Group. Centro de Investigaciones Biológicas del Noroeste, SC, Instituto Politécnico Nacional 195 , La Paz , México.
  • García-Silva I; Immunology & Vaccinology Group. Centro de Investigaciones Biológicas del Noroeste, SC, Instituto Politécnico Nacional 195 , La Paz , México.
  • Palestino G; Laboratorio de biofarmacéuticos recombinantes, Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí , San Luis Potosí , México.
  • Rosales-Mendoza S; Laboratorio de biopolímeros y nanoestructuras, Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí , San Luis Potosí , México.
Expert Rev Vaccines ; 18(9): 951-968, 2019 09.
Article em En | MEDLINE | ID: mdl-31487213
Introduction: The development of more efficacious vaccines, especially subunit vaccines administered via non-invasive routes, is a priority in vaccinology. Nanogels are materials that can meet the requirements to serve as efficient vaccine delivery vehicles (in terms of thermo-sensitivity, biocompatibility, and pH-responsiveness; among others); thus there is a growing interest in exploring the potential of nanogels for vaccine development. Areas covered: Herein, a critical analysis of nanogel synthesis methodologies is presented and nanogel-based vaccines under development are summarized and placed in perspective. Promising vaccine candidates based on nanogels have been reported for cancer, obesity, and infectious diseases (mainly respiratory diseases). Some of the candidates were administered by mucosal routes which are highly attractive in terms of simple administration and induction of protective responses at both mucosal and systemic levels. Expert opinion: The most advanced models of nanogel-based vaccines comprise candidates against cancer, based on cholesteryl pullulan nanogels evaluated in clinical trials with promising findings; as well as some vaccines against respiratory pathogens tested in mice thus far. Nonetheless, the challenge for this field is advancing in clinical trials and proving the protective potential in test animals for many other candidates. Implementing green synthesis approaches for nanogels is also required.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / Sistemas de Liberação de Medicamentos / Nanopartículas / Nanogéis Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Expert Rev Vaccines Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: México País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / Sistemas de Liberação de Medicamentos / Nanopartículas / Nanogéis Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Expert Rev Vaccines Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: México País de publicação: Reino Unido